What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Genetics, Molecular biology, Cancer research, Eukaryotic translation and Cell biology.
He has included themes like Messenger RNA, Gene and Candidate gene in his Molecular biology study.
The concepts of his Cancer research study are interwoven with issues in Carcinogenesis, Tumor suppressor gene, Frasier syndrome, Wilms' tumor and Gonadal ridge.
His Wilms' tumor research focuses on subjects like Wilms Tumor Protein, which are linked to Zinc finger, Gene expression, Germline mutation and Kidney development.
His research integrates issues of RNA, Five prime untranslated region, Target protein, EIF4E and Initiation factor in his study of Eukaryotic translation.
His study in Cell biology is interdisciplinary in nature, drawing from both Cancer cell and Cell culture.
His most cited work include:
- WT-1 is required for early kidney development (1695 citations)
- Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. (1633 citations)
- Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA (1592 citations)
What are the main themes of his work throughout his whole career to date?
Jerry Pelletier mainly investigates Cell biology, Molecular biology, Cancer research, Eukaryotic translation and Genetics.
His Cell biology research includes themes of Hippuristanol and Cell growth.
His work in Molecular biology addresses issues such as Messenger RNA, which are connected to fields such as Ribosome.
The various areas that Jerry Pelletier examines in his Cancer research study include Carcinogenesis, Cancer, Tumor suppressor gene, Wilms' tumor and PI3K/AKT/mTOR pathway.
His work investigates the relationship between Wilms' tumor and topics such as Denys–Drash syndrome that intersect with problems in Frasier syndrome.
His Eukaryotic translation research is multidisciplinary, relying on both eIF4A, Computational biology, Eukaryotic initiation factor and Initiation factor.
He most often published in these fields:
- Cell biology (24.66%)
- Molecular biology (23.84%)
- Cancer research (21.64%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (24.66%)
- eIF4A (12.60%)
- RNA (13.70%)
In recent papers he was focusing on the following fields of study:
His main research concerns Cell biology, eIF4A, RNA, Eukaryotic translation and Eukaryotic initiation factor.
His Cell biology research incorporates themes from Messenger RNA, Hippuristanol and Cell growth.
He has researched eIF4A in several fields, including EIF4A1, RNA Helicase A, DEAD box and Protein biosynthesis.
Many of his studies involve connections with topics such as Cancer research and Protein biosynthesis.
His Eukaryotic translation study incorporates themes from Gene expression, Computational biology, Small molecule and Initiation factor.
His Eukaryotic initiation factor study frequently draws parallels with other fields, such as EIF4E.
Between 2017 and 2021, his most popular works were:
- The Organizing Principles of Eukaryotic Ribosome Recruitment. (57 citations)
- Modulation of RNA Condensation by the DEAD-Box Protein eIF4A. (54 citations)
- CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. (38 citations)
In his most recent research, the most cited papers focused on:
EIF4A, Protein biosynthesis, Eukaryotic translation, Cell biology and Translation are his primary areas of study.
His biological study spans a wide range of topics, including EIF4E and Protein tyrosine phosphatase.
Within one scientific family, Jerry Pelletier focuses on topics pertaining to Genetic heterogeneity under EIF4E, and may sometimes address concerns connected to Cancer research.
The study incorporates disciplines such as RNA Helicase A, Gene expression and Computational biology in addition to Eukaryotic translation.
The concepts of his Cell biology study are interwoven with issues in Messenger RNA, EIF4G, Eukaryotic initiation factor and Lipoprotein.
Jerry Pelletier interconnects Cancer cell, Biological activity, Chemical synthesis and In vivo in the investigation of issues within Translation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
